2024/11/29 by Wadzanai Masvosva, Taija Voutilainen, Marko Lehtonen +5 · 1 voice
Medicine · Nursing · #Cancer Risks and Factors #Fatty Acid Research and Health #Smoking Behavior and Cessation
paper · pdf · doi:10.1101/2024.11.28.24318123
openalex publication_date 2024/11/29 · openalex created_date 2024/11/30 · openalex updated_date 2026/07/22
Abstract Tobacco smoking during pregnancy has been associated with an increased risk of adverse outcomes like low birth weight. This study determined changes in the circulating metabolome linked to maternal smoking in the first trimester and correlated these changes to the growth of the fetus. The circulating metabolome was examined from first trimester plasma samples by non-targeted (global) liquid chromatography mass spectrometry-based metabolite profiling of 227 pregnant women (99 smokers and 117 non-smokers) from the Kuopio Birth Cohort Study. Tobacco smoking was self-reported through a questionnaire and verified with cotinine measurements from plasma samples. In summary, 64 significant differences were observed between the groups after correction for multiple testing e.g. in metabolites indicating endocrine disruption (e.g., dehydroepiandrosterone sulfate [DHEA-S], VIP=2.70, d=0.68, p<0.0001), metabolites associated with oxidative stress (e.g., bilirubin, VIP=2.00, d=0.50, p<0.0001) and lipid metabolism (e.g., LysoPC 16:1, VIP=2.07, d=0.51, p<0.0001). Some of these metabolites, e.g., DHEA-S and bilirubin, correlated with low birth weight, and some, e.g. LysoPC 16:1, correlated with small head circumference at birth. In conclusion, maternal smoking during the first trimester of pregnancy was associated with an altered metabolite profile linked to endocrine disruption and increased oxidative stress. Plain language summary Tobacco smoking during pregnancy has been associated with an increased risk of adverse outcomes like low birth weight. In this study, we measured changes in the circulating metabolome linked to maternal smoking in the first trimester and correlated these changes to the growth of the fetus. Maternal smoking during the first trimester of pregnancy was associated with an altered metabolite profile linked to endocrine disruption and increased oxidative stress. Furthermore, some of these changes were associated with reduced fetal growth.